| # | Drug | Count |
|---|---|---|
| 0 | BEVACIZUMAB | 30 |
| 1 | CARBOPLATIN | 30 |
| 2 | TRAMETINIB | 13 |
| 3 | TEMOZOLOMIDE | 9 |
| 4 | DABRAFENIB | 7 |
| 5 | HYDROCORTISONE | 5 |
| 6 | SELUMETINIB | 5 |
| 7 | DEXAMETHASONE | 4 |
| 8 | DEXAMETHASONE 1.5 MG | 4 |
| 9 | LEVETIRACETAM | 4 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | SELUMETINIB | 5 | 0.0030 |
| 1 | TRAMETINIB | 13 | 0.0005 |
| 2 | TESTOSTERONE UNDECANOATE | 1 | 0.0005 |
| 3 | THIOGUANINE | 1 | 0.0005 |
| 4 | TEMOZOLOMIDE | 9 | 0.0004 |
| 5 | LOMUSTINE | 1 | 0.0004 |
| 6 | ESTROGEN | 1 | 0.0003 |
| 7 | DABRAFENIB | 7 | 0.0003 |
| 8 | DESMOPRESSIN ACETATE | 1 | 0.0003 |
| 9 | BEVACIZUMAB | 30 | 0.0002 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Vascular Endothelial Growth Factor Inhibitor [EPC] | 30 | 0.0002 |
| 1 | Platinum-based Drug [EPC] | 31 | 0.0001 |
| 2 | Tissue-nonspecific Alkaline Phosphatase [EPC] | 1 | 0.0001 |
| 3 | Recombinant Human Growth Hormone [EPC] | 2 | 0.0001 |
| 4 | Prostaglandin E1 Analog [EPC] | 1 | 0.0001 |
| 5 | Cystic Fibrosis Transmembrane Conductance Regulator Potentiator [EPC] | 1 | 0.0001 |
| 6 | Recombinant Human Deoxyribonuclease 1 [EPC] | 1 | 0.0001 |
| 7 | Alkylating Drug [EPC] | 10 | 0.0000 |
| 8 | Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] | 2 | 0.0000 |
| 9 | Typical Antipsychotic [EPC] | 1 | 0.0000 |